Keywords: s-p, begin, distribution, drug, using, cima, orasolv
S-P to begin distribution of drug using CIMA's OraSolv
Article | 05 September 2005
CIMA LABS, a division of US biotechnology firm Cephalon, says that Schering-Plough plans to market an orally-disintegrating version of Clarinex ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Pfizer to split-off remaining 80% interest in Zoetis
